Skip to content
Delayed ~15 min

DMAC DIAMEDICA THERAPEUTICS INC

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · after market close

What 7 analyst firms say about DIAMEDICA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works

9.36 USD+0.32 (+3.54%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+65.6%to the avg target 15.50 USD+6.14 USD
Buy 5 · Hold 1 · Sell 0

6 rated views · 7 analyst/firm records · 7 firms

Latest report11 Aug 2026avg report date 8 May
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)

Recent analyst activity · last 90 days

Our tracked history has 2 reports on DMAC from 2 analyst firms in the last 90 days (7 firms in the past year).

Comparing each firm's latest target with its previous one: 1 has its first observed target in the past year.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Cantor FitzgeraldJosh SchimmerBuy15 Jun 202625.00 USD
Craig-HallumChase KnickerbockerBuy18 Jun 202611.00 USD
H.C. WainwrightMatthew CaufieldBuy11 Aug 202612.00 USD
Lake Street Capital MarketsThomas FlatenBuy5 Jan 202614.00 USD · 14 Nov 2025
TD CowenStacy KuBuy15 Jun 2026—
Weiss RatingsUnnamed analyst—15 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 03:39 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.